Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial.
暂无分享,去创建一个
F. Kallel | J. Tijssen | T. Nazif | M. Leon | P. Pibarot | M. Maurer | O. Ben‐Yehuda | J. Rodés‐Cabau | A. Kappetein | W. Anderson | N. Van Mieghem | S. Kodali | G. van Es | R. Hahn | J. Paradis | E. Spitzer | O. Ben-Yehuda
[1] A. Dunning,et al. Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction. , 2016, European heart journal.
[2] J. Leipsic,et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis , 2016, The Lancet.
[3] P. Pibarot,et al. Echocardiographic predictors of outcomes in adults with aortic stenosis , 2016, Heart.
[4] M. Mack,et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.
[5] L. W. Andersen,et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.
[6] Akshay S. Desai,et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.
[7] Thoralf M Sundt,et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[8] Maurice Buchbinder,et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.
[9] T. Shiota,et al. Valvuloarterial Impedance, But Not Aortic Stenosis Severity, Predicts Syncope in Patients With Aortic Stenosis , 2013, Circulation. Cardiovascular imaging.
[10] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[11] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[12] A. Bogers,et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. , 2013, Journal of the American College of Cardiology.
[13] Thomas J. Wang,et al. The Epidemiology of Congestive Heart Failure: Contributions from the Framingham Heart Study , 2013 .
[14] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.
[15] M. Enriquez-Sarano,et al. Aortic valve stenosis in community medical practice: determinants of outcome and implications for aortic valve replacement. , 2012, The Journal of thoracic and cardiovascular surgery.
[16] G. Cioffi,et al. Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial) , 2012, Cardiovascular Ultrasound.
[17] O. Alfieri,et al. Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.
[18] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[19] S. Pocock,et al. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities , 2011, European heart journal.
[20] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[21] B. De Bruyne,et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. , 2011, Interactive cardiovascular and thoracic surgery.
[22] L. Stevenson,et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.
[23] F. Maisano,et al. Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis , 2011, Circulation.
[24] H. Eggebrecht,et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. , 2011, European heart journal.
[25] Alain Prat,et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. , 2011, European heart journal.
[26] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.
[27] H. Baumgartner,et al. Validation of conventional and simplified methods to calculate projected valve area at normal flow rate in patients with low flow, low gradient aortic stenosis: the multicenter TOPAS (True or Pseudo Severe Aortic Stenosis) study. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[28] Fabian Nietlispach,et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. , 2010, Journal of the American College of Cardiology.
[29] P. Pibarot,et al. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. , 2009, Journal of the American College of Cardiology.
[30] Philippe Pibarot,et al. Impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: influence of age, obesity, and left ventricular dysfunction. , 2009, Journal of the American College of Cardiology.
[31] H. Baumgartner,et al. Predictors of Outcomes in Low-Flow, Low-Gradient Aortic Stenosis: Results of the Multicenter TOPAS Study , 2008, Circulation.
[32] P. Serruys,et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[33] M. Zile,et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.
[34] Hans L Hillege,et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). , 2008, Archives of internal medicine.
[35] C. Tribouilloy,et al. Low‐Gradient Aortic Stenosis Operative Risk Stratification and Predictors for Long‐Term Outcome: A Multicenter Study Using Dobutamine Stress Hemodynamics , 2003, Circulation.
[36] D. Schoenfeld,et al. Combining mortality and longitudinal measures in clinical trials. , 1999, Statistics in medicine.
[37] A. Bolger,et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. , 1991, Journal of the American Dental Association.
[38] M A Gerber,et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. , 1990, JAMA.